{"id":451444,"date":"2021-03-04T17:06:12","date_gmt":"2021-03-04T22:06:12","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451444"},"modified":"2021-03-04T17:06:12","modified_gmt":"2021-03-04T22:06:12","slug":"sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/","title":{"rendered":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences"},"content":{"rendered":"

<\/p>\n

Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences<\/b><\/p>\n

WOODSTOCK, Ga.–(BUSINESS WIRE<\/a>)–
\nSonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that CEO Amy Trombly and CFO Jerry Dvonch will present at the following upcoming virtual conferences.\n<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n\n\u00a0<\/td>\n<\/tr>\n
\n

\nEvent\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nH.C. Wainwright Global Life Sciences Conference\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nMarch 9-10, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPresentation\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nAvailable on demand beginning March 9, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nEvent\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nMaxim Emerging Growth Conference\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nMarch 17-18, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPresentation\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nAvailable on demand beginning March 17, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\nInvestors interested in arranging a meeting with the Company\u2019s management for these conferences should contact the respective conference coordinator.\n<\/p>\n

\nThe presentations and panel will be available for registered attendees of each conference to view. Access to the H.C. Wainwright conference presentation will be available HERE<\/a>. Access to the Maxim conference presentation will be available HERE<\/a>. In addition, the presentation was furnished on a current report on Form 8-K with the U.S. Securities and Exchange Commission via EDGAR.\n<\/p>\n

About Sonoma Pharmaceuticals, Inc.<\/b><\/p>\n

\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company\u2019s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma\u2019s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company\u2019s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company\u2019s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com<\/a>. For partnership opportunities, please contact businessdevelopment@sonomapharma.com<\/a>.\n<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nExcept for historical information herein, matters set forth in this press release are forward-looking within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the \u201ccompany\u201d). These forward-looking statements are identified by the use of words such as \u201ccontinue,\u201d \u201cdevelop\u201d and \u201cexpand,\u201d among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company\u2019s business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company\u2019s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company\u2019s products will not be as large as expected, the company\u2019s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company\u2019s cash needs, fund further development, as well as uncertainties relative to the COVID-19 pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company\u2019s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law.\n<\/p>\n

\nSonoma Pharmaceuticals\u2122 is a trademark or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210304006115\/en\/<\/a><\/span><\/p>\n

Media and Investor Contact:
\n<\/i><\/b>
Sonoma Pharmaceuticals, Inc.
\n<\/i><\/b>
ir@sonomapharma.com<\/a><\/p>\n

KEYWORDS:<\/b> Georgia United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> General Health Pharmaceutical Health Medical Supplies<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences WOODSTOCK, Ga.–(BUSINESS WIRE)– Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that CEO Amy Trombly and CFO Jerry Dvonch will present at the following upcoming virtual conferences. \u00a0 Event \u00a0 H.C. Wainwright Global Life Sciences Conference Date \u00a0 March 9-10, 2021 Presentation \u00a0 Available on demand beginning March 9, 2021 \u00a0 \u00a0 \u00a0 Event \u00a0 Maxim Emerging Growth Conference Date \u00a0 March 17-18, 2021 Presentation \u00a0 Available on demand beginning March 17, 2021 \u00a0 Investors interested in arranging a meeting with … <\/p>\n

Continue reading “Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451444","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences WOODSTOCK, Ga.–(BUSINESS WIRE)– Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that CEO Amy Trombly and CFO Jerry Dvonch will present at the following upcoming virtual conferences. \u00a0 Event \u00a0 H.C. Wainwright Global Life Sciences Conference Date \u00a0 March 9-10, 2021 Presentation \u00a0 Available on demand beginning March 9, 2021 \u00a0 \u00a0 \u00a0 Event \u00a0 Maxim Emerging Growth Conference Date \u00a0 March 17-18, 2021 Presentation \u00a0 Available on demand beginning March 17, 2021 \u00a0 Investors interested in arranging a meeting with … Continue reading "Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T22:06:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences\",\"datePublished\":\"2021-03-04T22:06:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/\"},\"wordCount\":696,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/\",\"name\":\"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-03-04T22:06:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk","og_description":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences WOODSTOCK, Ga.–(BUSINESS WIRE)– Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that CEO Amy Trombly and CFO Jerry Dvonch will present at the following upcoming virtual conferences. \u00a0 Event \u00a0 H.C. Wainwright Global Life Sciences Conference Date \u00a0 March 9-10, 2021 Presentation \u00a0 Available on demand beginning March 9, 2021 \u00a0 \u00a0 \u00a0 Event \u00a0 Maxim Emerging Growth Conference Date \u00a0 March 17-18, 2021 Presentation \u00a0 Available on demand beginning March 17, 2021 \u00a0 Investors interested in arranging a meeting with … Continue reading \"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T22:06:12+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences","datePublished":"2021-03-04T22:06:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/"},"wordCount":696,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/","name":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-03-04T22:06:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210304006115r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-to-present-at-upcoming-spring-virtual-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451444"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451444\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}